Clinical Trials Browser

Interventional × Neurodegenerative Diseases × Clear all

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Tauopathies

NCT05321498 2023-09-28

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Phase 2 Withdrawn

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Tauopathies, Cognitive Dysfunction

NCT02452216 2017-08-31

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Phase EARLY_PHASE1 Completed

10 enrolled

CNS

Ischemic Stroke, Hemorrhagic Stroke, Brain Injuries, Brain Neoplasms, Central Nervous System Infections, Neurodegenerative Diseases, Central Nervous System Vascular Malformations

NCT01969370 2017-05-03

NCGENES

Phase NA Completed

645 enrolled

Congenital Abnormalities, Cardiovascular Diseases, Neoplasms, Neurologic Manifestations, Neurodegenerative Diseases, Hearing Loss

NCT02108769 2014-04-09

Yogic Breathing Changes Salivary Components

Phase NA Completed

20 enrolled

Alzheimer Disease, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Neurodegenerative Diseases

NCT00643890 2012-02-22

Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease

Phase 2 Terminated

44 enrolled

CNS

Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, Movement Disorders, Nervous System Diseases, Parkinson Disease, Neurodegenerative Diseases, Parkinsonian Disorders, Ganglion Cysts

Clinical Trials

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

NCGENES

Yogic Breathing Changes Salivary Components

Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease